Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 2000 Jul;64(3):171–177.

Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.

G R Haines 1, M P Brown 1, R R Gronwall 1, K A Merritt 1
PMCID: PMC1189609  PMID: 10935883

Abstract

Serum concentrations and pharmacokinetics of enrofloxacin were studied in 6 mares after intravenous (IV) and intragastric (IG) administration at a single dose rate of 7.5 mg/kg body weight. In experiment 1, an injectable formulation of enrofloxacin (100 mg/mL) was given IV. At 5 min after injection, mean serum concentration was 9.04 microg/mL and decreased to 0.09 microg/mL by 24 h. Elimination half-life was 5.33 +/- 1.05 h and the area under the serum concentration vs time curve (AUC) was 21.03 +/- 5.19 mg x h/L. In experiment 2, the same injectable formulation was given IG. The mean peak serum concentration was 0.94 +/- 0.97 microg/mL at 4 h after administration and declined to 0.29 +/- 0.12 microg/mL by 24 h. Absorption of this enrofloxacin preparation after IG administration was highly variable, and for this reason, pharmacokinetic values for each mare could not be determined. In experiment 3, a poultry formulation (32.3 mg/mL) was given IG. The mean peak serum concentration was 1.85 +/- 1.47 microg/mL at 45 min after administration and declined to 0.19 +/- 0.06 microg/mL by 24 h. Elimination half-life was 10.62 +/- 5.33 h and AUC was 16.30 +/- 4.69 mg x h/L. Bioavailability was calculated at 78.29 +/- 16.55%. Minimum inhibitory concentrations of enrofloxacin were determined for equine bacterial culture specimens submitted to the microbiology laboratory over an 11-month period. The minimum inhibitory concentration of enrofloxacin required to inhibit 90% of isolates (MIC90) was 0.25 microg/mL for Staphylococcus aureus, Escherichia coli, Salmonella spp., Klebsiella spp., and Pasteurella spp. The poultry formulation was well tolerated and could be potentially useful in the treatment of susceptible bacterial infections in adult horses. The injectable enrofloxacin solution should not be used orally.

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burkhardt J. E., Hill M. A., Carlton W. W., Kesterson J. W. Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol. 1990 May;27(3):162–170. doi: 10.1177/030098589002700303. [DOI] [PubMed] [Google Scholar]
  3. Burkhardt J. E., Hill M. A., Carlton W. W. Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin. Toxicol Pathol. 1992;20(2):246–252. doi: 10.1177/019262339202000211. [DOI] [PubMed] [Google Scholar]
  4. Burkhardt J. E., Hill M. A., Turek J. J., Carlton W. W. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol. 1992 May;29(3):230–238. doi: 10.1177/030098589202900307. [DOI] [PubMed] [Google Scholar]
  5. Drusano G. L., Johnson D. E., Rosen M., Standiford H. C. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother. 1993 Mar;37(3):483–490. doi: 10.1128/aac.37.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ensink J. M., van Klingeren B., Houwers D. J., Klein W. R., Vulto A. G. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine Vet J. 1993 Jul;25(4):309–313. doi: 10.1111/j.2042-3306.1993.tb02969.x. [DOI] [PubMed] [Google Scholar]
  7. Forrest A., Nix D. E., Ballow C. H., Goss T. F., Birmingham M. C., Schentag J. J. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother. 1993 May;37(5):1073–1081. doi: 10.1128/aac.37.5.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Giguère S., Bélanger M. Concentration of enrofloxacin in equine tissues after long-term oral administration. J Vet Pharmacol Ther. 1997 Oct;20(5):402–404. doi: 10.1046/j.1365-2885.1997.00071.x. [DOI] [PubMed] [Google Scholar]
  9. Giguère S., Sweeney R. W., Bélanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res. 1996 Jul;57(7):1025–1030. [PubMed] [Google Scholar]
  10. Gough A. W., Kasali O. B., Sigler R. E., Baragi V. Quinolone arthropathy--acute toxicity to immature articular cartilage. Toxicol Pathol. 1992;20(3 Pt 1):436–450. doi: 10.1177/019262339202000313. [DOI] [PubMed] [Google Scholar]
  11. Hawkins J. F., Bowman K. F., Roberts M. C., Cowen P. Peritonitis in horses: 67 cases (1985-1990). J Am Vet Med Assoc. 1993 Jul 15;203(2):284–288. [PubMed] [Google Scholar]
  12. Johnston J. K., Divers T. J., Reef V. B., Acland H. Cholelithiasis in horses: ten cases (1982-1986). J Am Vet Med Assoc. 1989 Feb 1;194(3):405–409. [PubMed] [Google Scholar]
  13. Kaartinen L., Panu S., Pyörälä S. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet J. 1997 Sep;29(5):378–381. doi: 10.1111/j.2042-3306.1997.tb03143.x. [DOI] [PubMed] [Google Scholar]
  14. Langston V. C., Sedrish S., Boothe D. M. Disposition of single-dose oral enrofloxacin in the horse. J Vet Pharmacol Ther. 1996 Aug;19(4):316–319. doi: 10.1111/j.1365-2885.1996.tb00057.x. [DOI] [PubMed] [Google Scholar]
  15. Meinen J. B., McClure J. T., Rosin E. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. Am J Vet Res. 1995 Sep;56(9):1219–1224. [PubMed] [Google Scholar]
  16. Moore R. M., Schneider R. K., Kowalski J., Bramlage L. R., Mecklenburg L. M., Kohn C. W. Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Vet J. 1992 Nov;24(6):450–456. doi: 10.1111/j.2042-3306.1992.tb02875.x. [DOI] [PubMed] [Google Scholar]
  17. Norrby S. R. Side-effects of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):378–383. doi: 10.1007/BF01967014. [DOI] [PubMed] [Google Scholar]
  18. Prescott J. F., Yielding K. M. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res. 1990 Jan;54(1):195–197. [PMC free article] [PubMed] [Google Scholar]
  19. Stahlmann R., Förster C., Shakibaei M., Vormann J., Günther T., Merker H. J. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother. 1995 Sep;39(9):2013–2018. doi: 10.1128/aac.39.9.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sullivan M. C., Cooper B. W., Nightingale C. H., Quintiliani R., Lawlor M. T. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother. 1993 Feb;37(2):234–239. doi: 10.1128/aac.37.2.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sweeney C. R., Holcombe S. J., Barningham S. C., Beech J. Aerobic and anaerobic bacterial isolates from horses with pneumonia or pleuropneumonia and antimicrobial susceptibility patterns of the aerobes. J Am Vet Med Assoc. 1991 Mar 1;198(5):839–842. [PubMed] [Google Scholar]
  22. Takada S., Kato M., Takayama S. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles. J Toxicol Environ Health. 1994 May;42(1):73–88. doi: 10.1080/15287399409531864. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES